News
SNNUF
14.50
NaN%
--
Smith & Nephew: Improving And Undervalued, But Mind The Knees
Seeking Alpha · 01/08 03:47
Panmure Gordon Reiterates Smith & Nephew (SNNUF) Hold Recommendation
NASDAQ · 12/17/2025 08:03
JP Morgan Cazenove Reiterates Smith & Nephew (SNNUF) Overweight Recommendation
NASDAQ · 11/09/2025 00:39
Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release
Seeking Alpha · 11/05/2025 14:58
Weekly Report: what happened at SNNUF last week (0908-0912)?
Weekly Report · 09/15/2025 11:17
Weekly Report: what happened at SNNUF last week (0901-0905)?
Weekly Report · 09/08/2025 11:20
Weekly Report: what happened at SNNUF last week (0825-0829)?
Weekly Report · 09/01/2025 11:14
Weekly Report: what happened at SNNUF last week (0818-0822)?
Weekly Report · 08/25/2025 11:26
Weekly Report: what happened at SNNUF last week (0811-0815)?
Weekly Report · 08/18/2025 11:17
Weekly Report: what happened at SNNUF last week (0804-0808)?
Weekly Report · 08/11/2025 11:25
Smith & Nephew Non-GAAP EPS of $0.43, revenue of $2.96B; reaffirms FY outlook
Seeking Alpha · 08/05/2025 09:11
Weekly Report: what happened at SNNUF last week (0728-0801)?
Weekly Report · 08/04/2025 11:28
Smith & Nephew: Investors Looking To Continued Innovation & Margin Growth In Q2 Earnings
Seeking Alpha · 07/29/2025 17:50
Weekly Report: what happened at SNNUF last week (0721-0725)?
Weekly Report · 07/28/2025 11:28
Weekly Report: what happened at SNNUF last week (0714-0718)?
Weekly Report · 07/21/2025 11:18
Weekly Report: what happened at SNNUF last week (0707-0711)?
Weekly Report · 07/14/2025 11:28
Weekly Report: what happened at SNNUF last week (0630-0704)?
Weekly Report · 07/07/2025 11:18
More
Webull provides a variety of real-time SNNUF stock news. You can receive the latest news about Smith & Nephew Plc through multiple platforms. This information may help you make smarter investment decisions.
About SNNUF
Smith & Nephew plc is a portfolio medical technology company. The Company is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, which includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilize severe fractures and correct bone deformities; Sports Medicine & ENT businesses offer advanced products and instruments used to repair or remove soft tissue, and Advanced Wound Management provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds. The Company also owns Integrity Orthopaedics, which is an early stage commercial developer of Tendon Seam, an innovative and disruptive biomechanical RCR system.